查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1839188

2034 年治疗诊断学市场分析及预测：类型、产品、服务、技术、组件、应用、最终用户、设备和流程

Theranostics Market Analysis and Forecast to 2034: Type, Product, Services, Technology, Component, Application, End User, Device, Process
出版日期: | 出版商: Global Insight Services | 英文 397 Pages | 商品交期: 3-5个工作天内

价格
简介目录

预计到2034年，治疗诊断学市场规模将从2024年的36亿美元增加到118亿美元，复合年增长率约为12.6%。治疗诊断学市场透过将治疗和诊断功能整合到单一平台，从而实现个人化治疗策略。这种创新方法将标靶治疗与影像学和生物标记相结合，以增强疗效并监测治疗反应。随着精准医疗的日益普及，在分子成像、奈米技术和生物标记发现的推动下，治疗诊断学有望显着成长。癌症发生率的上升以及对个人化医疗解决方案的需求进一步推动了该市场的发展，为製药和诊断行业的相关人员创造了巨大的商机。

预计治疗诊断学市场将出现显着成长，这主要归功于个人化医疗中诊断和治疗药物的整合。放射性药物引领市场，其中放射性同位素和放射性标记肽对于增强癌症的标靶治疗至关重要。紧随其后的是影像领域，包括 PET 和 SPECT 技术，突显了它们在准确疾病诊断中的重要性。肿瘤学子领域表现最佳，这得益于癌症发生率上升和对标靶治疗的需求。心血管治疗诊断是第二大子领域，由于心臟病影像诊断技术的进步而获得发展动力。製药公司和诊断公司之间日益增多的合作正在加速该领域的技术创新。此外，人工智慧在影像和诊断中的整合正在提高治疗诊断解决方案的准确性和效率。随着患者和医疗保健提供者寻求更安全、更有效的治疗方法，对微创手术的需求进一步推动了市场成长。

市场区隔
类型 影像剂、治疗剂、放射性同位素、生物标记、奈米粒子、小分子、抗体、胜肽、基因治疗
产品 套件、试剂、仪器、软体、耗材、检测系统、诊断设备、治疗设备
服务 咨询、维护、安装、培训、数据分析、远端监控
科技 PCR、NGS、免疫检测、质谱、微阵列、流式细胞技术、液态切片
成分 硬体、软体和服务
目的 肿瘤科、神经科、循环系统、感染疾病科、内分泌科、胃肠科、呼吸科
最终用户 医院、诊断实验室、研究机构、製药公司、生技公司、学术机构
装置 PET扫描仪、MRI扫描仪、CT扫描仪、超音波设备、伽马摄影机
过程 体内、体外

市场概述

在创新定价策略和新产品推出激增的推动下，治疗诊断学市场正经历市场份额的动态变化。行业主要企业正在利用先进技术提供具有竞争力的价格，提高可及性和采用率。市场的特点是新产品不断涌入，反映出强大的开发平臺，以满足日益增长的个人化医疗需求。这一趋势凸显了该行业致力于整合治疗和诊断能力，使其处于精准医疗的前沿。竞争基准基准化分析表明，策略联盟和合併正在推动竞争优势。监管影响巨大，严格的指导方针决定市场进入和产品开发。虽然市场环境由少数主要企业主导，但由创新和策略伙伴关係关係驱动的新兴企业正在取得重大进展。北美和欧洲的法规结构尤其具有影响力，它们塑造着市场动态并创造了有利于成长的竞争环境。市场未来前景光明，技术进步和监管支援为持续扩张铺平了道路。

主要趋势和驱动因素：

在个人化医疗和标靶治疗的推动下，治疗诊断学市场正经历强劲成长。一个关键趋势是整合诊断和治疗能力，以提高治疗的准确性和有效性。随着医疗保健系统努力为患者提供更个人化的治疗，这种方法越来越受到关注。癌症和心血管疾病等慢性疾病的日益普及是一个关键驱动因素。这些疾病需要创新的治疗方案，进一步推动了治疗诊断学的应用。此外，诊断影像技术的进步正在提高诊断的准确性，从而实现更早的发现和早期疗育。伴随诊断的兴起也是一个值得注意的趋势，它支持个人化治疗方法的发展。治疗诊断产品监管核准的增加趋势反映出人们对其潜力的信心日益增强。随着医疗基础设施的发展和对先进疗法的需求的增加，新兴市场提供了重大机会。投资研发的公司完全有能力利用这些不断扩大的机会，并将自己定位为不断发展的治疗诊断学领域的领导者。

限制与挑战：

治疗诊断学市场面临一些显着的限制和挑战。一个关键挑战是整合诊断和治疗技术的成本高昂，这给医疗服务提供者和患者带来了经济负担。这种经济障碍限制了该技术的可及性和采用率，尤其是在新兴市场。监管复杂性也是一个重大挑战。治疗诊断产品复杂的核准流程可能会延迟市场进入并增加开发成本。此外，不同地区缺乏标准化的法律规范，进一步加剧了全球市场扩张的复杂性。另一个挑战是医疗专业人员对治疗治疗诊断学的认识和理解有限。这种知识差距可能会阻碍这些技术在临床环境中的有效实施，并限制潜在的效益。此外，该领域技术的快速进步需要持续的研发投入。这种需求给公司带来了压力，要求他们在管理财务永续性的同时进行创新。最后，治疗诊断应用中与病患资讯相关的资料隐私问题构成了一大障碍。确保强有力的资料保护措施对于赢得病患信任和遵守法规至关重要。

主要企业

Advanced Accelerator Applications、Theragnostics、Lantheus Holdings、NanoMab Technology、Radiomedix、Telix Pharmaceuticals、Blue Earth Diagnostics、Isotopia Molecular Imaging、Sofie Biosciences、Endocyte、Navidea Biopharmaceuticals、Crvcloc​​U​​c​​x集）

目录

第一章治疗诊断学市场概述

  • 调查目的
  • 治疗诊断学市场定义和范围
  • 报告限制
  • 调查年份和货币
  • 调查方法

第二章执行摘要

第三章：重要考察

第四章治疗诊断学市场展望

  • 治疗诊断学市场区隔
  • 市场动态
  • 波特五力分析
  • PESTLE分析
  • 价值链分析
  • 4P模型
  • 安索夫矩阵

第五章治疗诊断学市场策略

  • 母市场分析
  • 供需分析
  • 消费者购买意向
  • 案例研究分析
  • 定价分析
  • 监管状况
  • 供应链分析
  • 竞争产品分析
  • 近期动态

第六章治疗诊断学市场规模

  • 治疗诊断学市场规模（按价值）
  • 治疗诊断学市场规模（按数量）

第七章治疗诊断学市场（按类型）

  • 市场概况
  • 显影剂
  • 治疗药物
  • 放射性同位素
  • 生物标誌物
  • 奈米粒子
  • 低分子
  • 抗体
  • 胜肽
  • 基因治疗
  • 其他的

第 8 章治疗诊断学市场（按产品）

  • 市场概况
  • 套件
  • 试剂
  • 装置
  • 软体
  • 耗材
  • 检测系统
  • 诊断设备
  • 治疗设备
  • 其他的

第九章治疗诊断学市场（按服务）

  • 市场概况
  • 咨询
  • 维护
  • 安装
  • 训练
  • 数据分析
  • 远端监控
  • 其他的

第 10 章治疗诊断学市场（按技术）

  • 市场概况
  • PCR
  • NGS
  • 免疫检测
  • 质谱法
  • 微阵列
  • 流式细胞技术
  • 液态切片
  • 其他的

第 11 章治疗诊断学市场：按组成部分

  • 市场概况
  • 硬体
  • 软体
  • 服务
  • 其他的

第 12 章治疗诊断学市场（按应用）

  • 市场概况
  • 肿瘤学
  • 神经病学
  • 循环系统
  • 感染疾病
  • 内分泌学
  • 胃肠病学
  • 呼吸系统医疗设备
  • 其他的

第 13 章治疗诊断学市场：按最终用户

  • 市场概况
  • 医院
  • 诊断实验室
  • 研究所
  • 製药公司
  • 生技公司
  • 学术机构
  • 其他的

第 14 章治疗诊断学市场（按设备）

  • 市场概况
  • PET扫描仪
  • MRI扫描仪
  • CT扫描仪
  • 超音波设备
  • 伽马摄影机
  • 其他的

第 15 章治疗诊断学市场：依流程

  • 市场概况
  • 体内
  • 体外
  • 其他的

第十六章治疗诊断学市场（按地区）

  • 概述
  • 北美洲
    • 美国
    • 加拿大
  • 欧洲
    • 英国
    • 德国
    • 法国
    • 西班牙
    • 义大利
    • 荷兰
    • 瑞典
    • 瑞士
    • 丹麦
    • 芬兰
    • 俄罗斯
    • 其他欧洲国家
  • 亚太地区
    • 中国
    • 印度
    • 日本
    • 韩国
    • 澳洲
    • 新加坡
    • 印尼
    • 台湾
    • 马来西亚
    • 其他亚太地区
  • 拉丁美洲
    • 巴西
    • 墨西哥
    • 阿根廷
    • 其他拉丁美洲
  • 中东和非洲
    • 沙乌地阿拉伯
    • 阿拉伯聯合大公国
    • 南非
    • 其他中东和非洲地区

第十七章竞争格局

  • 概述
  • 市占率分析
  • 主要企业定位
  • 衝突领导地图
  • 供应商基准化分析
  • 发展策略基准化分析

第十八章：公司简介

  • Advanced Accelerator Applications
  • Theragnostics
  • Lantheus Holdings
  • NanoMab Technology
  • Radiomedix
  • Telix Pharmaceuticals
  • Blue Earth Diagnostics
  • Isotopia Molecular Imaging
  • Sofie Biosciences
  • Endocyte
  • Navidea Biopharmaceuticals
  • Cyclopharm
  • ImaginAb
  • OncoNano Medicine
  • Cerveau Technologies
简介目录
Product Code: GIS34343

Theranostics Market is anticipated to expand from $3.6 billion in 2024 to $11.8 billion by 2034, growing at a CAGR of approximately 12.6%. The Theranostics Market encompasses the integration of therapeutic and diagnostic capabilities within a single platform, enabling personalized treatment strategies. This innovative approach combines targeted therapies with diagnostic imaging or biomarkers to enhance treatment efficacy and monitor therapeutic responses. As precision medicine gains traction, theranostics is poised for significant growth, driven by advancements in molecular imaging, nanotechnology, and biomarker discovery. The market is further propelled by increasing cancer prevalence and the demand for tailored healthcare solutions, promising substantial opportunities for stakeholders in the pharmaceutical and diagnostic sectors.

The Theranostics Market is poised for substantial growth, primarily driven by the integration of diagnostics and therapeutics in personalized medicine. Radiopharmaceuticals lead the market, with radioisotopes and radiolabeled peptides being pivotal in enhancing targeted cancer treatment. The imaging segment, comprising PET and SPECT technologies, follows closely, underscoring their importance in precise disease diagnosis. The oncology sub-segment is the top performer, driven by the rising prevalence of cancer and the need for targeted therapies. Cardiovascular theranostics, as the second highest performing sub-segment, is gaining momentum due to advancements in imaging agents for heart disease. Increasing collaboration between pharmaceutical companies and diagnostic firms is accelerating innovation in this field. Additionally, the integration of artificial intelligence in imaging and diagnostics is enhancing the accuracy and efficiency of theranostic solutions. The demand for minimally invasive procedures is further propelling market growth, as patients and healthcare providers seek safer and more effective treatment options.

Market Segmentation
TypeImaging Agents, Therapeutic Agents, Radioisotopes, Biomarkers, Nanoparticles, Small Molecules, Antibodies, Peptides, Gene Therapy
ProductKits, Reagents, Instruments, Software, Consumables, Assay Systems, Diagnostic Devices, Therapeutic Devices
ServicesConsultation, Maintenance, Installation, Training, Data Analysis, Remote Monitoring
TechnologyPCR, NGS, Immunoassays, Mass Spectrometry, Microarrays, Flow Cytometry, Liquid Biopsies
ComponentHardware, Software, Services
ApplicationOncology, Neurology, Cardiology, Infectious Diseases, Endocrinology, Gastroenterology, Respiratory
End UserHospitals, Diagnostic Laboratories, Research Institutes, Pharmaceutical Companies, Biotechnology Companies, Academic Institutions
DevicePET Scanners, MRI Scanners, CT Scanners, Ultrasound Devices, Gamma Cameras
ProcessIn Vivo, In Vitro

Market Snapshot:

The Theranostics market is witnessing a dynamic shift in market share, driven by innovative pricing strategies and a surge in new product launches. Key industry players are leveraging advanced technologies to offer competitive pricing, enhancing accessibility and adoption. The market is characterized by a continuous influx of novel products, reflecting a robust pipeline of developments aimed at meeting the growing demand for personalized medicine. This trend underscores the industry's commitment to integrating therapeutic and diagnostic capabilities, positioning itself at the forefront of precision healthcare. Competition benchmarking reveals a landscape marked by strategic alliances and mergers, enhancing competitive advantage. Regulatory influences are pivotal, with stringent guidelines shaping market entry and product development. The landscape is dominated by a few key players, yet emerging companies are making significant inroads, driven by innovation and strategic partnerships. Regulatory frameworks in North America and Europe are particularly influential, dictating market dynamics and fostering a competitive environment ripe for growth. The market's future is promising, with technological advancements and regulatory support paving the way for continued expansion.

Geographical Overview:

The theranostics market is witnessing notable expansion across various regions, each exhibiting unique growth dynamics. North America is at the forefront, driven by advanced healthcare infrastructure and significant investments in personalized medicine. The region's focus on integrating diagnostics and therapeutics enhances its market leadership. Europe follows closely, with strong regulatory support and a growing emphasis on precision medicine fostering a conducive environment for theranostics. Asia Pacific is rapidly emerging as a lucrative market, propelled by substantial investments in healthcare and technological advancements. Countries like China and India are spearheading growth, driven by increasing healthcare expenditures and a rising demand for personalized treatment solutions. Latin America and the Middle East & Africa are also showing promising growth potential. In Latin America, improving healthcare infrastructure and rising awareness of personalized medicine are key drivers. Meanwhile, the Middle East & Africa are recognizing the value of theranostics in addressing regional healthcare challenges and improving patient outcomes.

Key Trends and Drivers:

The theranostics market is experiencing robust growth, propelled by advancements in personalized medicine and targeted therapies. A key trend is the integration of diagnostic and therapeutic capabilities, which enhances treatment precision and efficacy. This approach is gaining traction as healthcare systems aim to provide more tailored patient care. Increasing prevalence of chronic diseases, such as cancer and cardiovascular disorders, is a significant driver. These conditions necessitate innovative treatment solutions, further fueling theranostics adoption. Additionally, advancements in imaging technologies are enhancing diagnostic accuracy, enabling early detection and intervention. The rise of companion diagnostics is another notable trend, supporting the development of personalized treatment regimens. Regulatory bodies are increasingly approving theranostic products, reflecting growing confidence in their potential. Emerging markets present lucrative opportunities as healthcare infrastructure improves and demand for advanced treatments rises. Companies investing in research and development are poised to capitalize on these expanding opportunities, positioning themselves as leaders in the evolving theranostics landscape.

Restraints and Challenges:

The Theranostics Market encounters several notable restraints and challenges. A primary challenge is the substantial cost associated with integrating diagnostic and therapeutic technologies, which imposes financial burdens on healthcare providers and patients alike. This financial barrier limits accessibility and adoption, particularly in emerging markets. Regulatory complexities also pose significant challenges. Navigating the intricate approval processes for theranostic products can delay market entry and increase development costs. Moreover, the lack of standardized regulatory frameworks across different regions further complicates global market expansion. Another challenge is the limited awareness and understanding of theranostics among healthcare professionals. This knowledge gap can impede the effective implementation of these technologies in clinical settings, restricting their potential benefits. Additionally, the rapid pace of technological advancements in the field requires continuous investment in research and development. This necessity places pressure on companies to innovate while managing financial sustainability. Lastly, data privacy concerns related to patient information in theranostic applications present a significant hurdle. Ensuring robust data protection measures is crucial to gaining patient trust and regulatory compliance.

Key Players:

Advanced Accelerator Applications, Theragnostics, Lantheus Holdings, NanoMab Technology, Radiomedix, Telix Pharmaceuticals, Blue Earth Diagnostics, Isotopia Molecular Imaging, Sofie Biosciences, Endocyte, Navidea Biopharmaceuticals, Cyclopharm, ImaginAb, OncoNano Medicine, Cerveau Technologies

Research Scope:

  • Estimates and forecasts the overall market size across type, application, and region.
  • Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
  • Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
  • Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
  • Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
  • Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
  • Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1: Theranostics Market Overview

  • 1.1 Objectives of the Study
  • 1.2 Theranostics Market Definition and Scope of the Report
  • 1.3 Report Limitations
  • 1.4 Years & Currency Considered in the Study
  • 1.5 Research Methodologies
    • 1.5.1 Secondary Research
    • 1.5.2 Primary Research
    • 1.5.3 Market Size Estimation: Top-Down Approach
    • 1.5.4 Market Size Estimation: Bottom-Up Approach
    • 1.5.5 Data Triangulation and Validation

2: Executive Summary

  • 2.1 Summary
  • 2.2 Key Opinion Leaders
  • 2.3 Key Highlights of the Market, by Type
  • 2.4 Key Highlights of the Market, by Product
  • 2.5 Key Highlights of the Market, by Services
  • 2.6 Key Highlights of the Market, by Technology
  • 2.7 Key Highlights of the Market, by Component
  • 2.8 Key Highlights of the Market, by Application
  • 2.9 Key Highlights of the Market, by End User
  • 2.10 Key Highlights of the Market, by Device
  • 2.11 Key Highlights of the Market, by Process
  • 2.12 Key Highlights of the Market, by North America
  • 2.13 Key Highlights of the Market, by Europe
  • 2.14 Key Highlights of the Market, by Asia-Pacific
  • 2.15 Key Highlights of the Market, by Latin America
  • 2.16 Key Highlights of the Market, by Middle East
  • 2.17 Key Highlights of the Market, by Africa

3: Premium Insights on the Market

  • 3.1 Market Attractiveness Analysis, by Region
  • 3.2 Market Attractiveness Analysis, by Type
  • 3.3 Market Attractiveness Analysis, by Product
  • 3.4 Market Attractiveness Analysis, by Services
  • 3.5 Market Attractiveness Analysis, by Technology
  • 3.6 Market Attractiveness Analysis, by Component
  • 3.7 Market Attractiveness Analysis, by Application
  • 3.8 Market Attractiveness Analysis, by End User
  • 3.9 Market Attractiveness Analysis, by Device
  • 3.10 Market Attractiveness Analysis, by Process
  • 3.11 Market Attractiveness Analysis, by North America
  • 3.12 Market Attractiveness Analysis, by Europe
  • 3.13 Market Attractiveness Analysis, by Asia-Pacific
  • 3.14 Market Attractiveness Analysis, by Latin America
  • 3.15 Market Attractiveness Analysis, by Middle East
  • 3.16 Market Attractiveness Analysis, by Africa

4: Theranostics Market Outlook

  • 4.1 Theranostics Market Segmentation
  • 4.2 Market Dynamics
    • 4.2.1 Market Drivers
    • 4.2.2 Market Trends
    • 4.2.3 Market Restraints
    • 4.2.4 Market Opportunities
  • 4.3 Porters Five Forces Analysis
    • 4.3.1 Threat of New Entrants
    • 4.3.2 Threat of Substitutes
    • 4.3.3 Bargaining Power of Buyers
    • 4.3.4 Bargaining Power of Supplier
    • 4.3.5 Competitive Rivalry
  • 4.4 PESTLE Analysis
  • 4.5 Value Chain Analysis
  • 4.6 4Ps Model
  • 4.7 ANSOFF Matrix

5: Theranostics Market Strategy

  • 5.1 Parent Market Analysis
  • 5.2 Supply-Demand Analysis
  • 5.3 Consumer Buying Interest
  • 5.4 Case Study Analysis
  • 5.5 Pricing Analysis
  • 5.6 Regulatory Landscape
  • 5.7 Supply Chain Analysis
  • 5.8 Competition Product Analysis
  • 5.9 Recent Developments

6: Theranostics Market Size

  • 6.1 Theranostics Market Size, by Value
  • 6.2 Theranostics Market Size, by Volume

7: Theranostics Market, by Type

  • 7.1 Market Overview
  • 7.2 Imaging Agents
    • 7.2.1 Key Market Trends & Opportunity Analysis
    • 7.2.2 Market Size and Forecast, by Region
  • 7.3 Therapeutic Agents
    • 7.3.1 Key Market Trends & Opportunity Analysis
    • 7.3.2 Market Size and Forecast, by Region
  • 7.4 Radioisotopes
    • 7.4.1 Key Market Trends & Opportunity Analysis
    • 7.4.2 Market Size and Forecast, by Region
  • 7.5 Biomarkers
    • 7.5.1 Key Market Trends & Opportunity Analysis
    • 7.5.2 Market Size and Forecast, by Region
  • 7.6 Nanoparticles
    • 7.6.1 Key Market Trends & Opportunity Analysis
    • 7.6.2 Market Size and Forecast, by Region
  • 7.7 Small Molecules
    • 7.7.1 Key Market Trends & Opportunity Analysis
    • 7.7.2 Market Size and Forecast, by Region
  • 7.8 Antibodies
    • 7.8.1 Key Market Trends & Opportunity Analysis
    • 7.8.2 Market Size and Forecast, by Region
  • 7.9 Peptides
    • 7.9.1 Key Market Trends & Opportunity Analysis
    • 7.9.2 Market Size and Forecast, by Region
  • 7.10 Gene Therapy
    • 7.10.1 Key Market Trends & Opportunity Analysis
    • 7.10.2 Market Size and Forecast, by Region
  • 7.11 Others
    • 7.11.1 Key Market Trends & Opportunity Analysis
    • 7.11.2 Market Size and Forecast, by Region

8: Theranostics Market, by Product

  • 8.1 Market Overview
  • 8.2 Kits
    • 8.2.1 Key Market Trends & Opportunity Analysis
    • 8.2.2 Market Size and Forecast, by Region
  • 8.3 Reagents
    • 8.3.1 Key Market Trends & Opportunity Analysis
    • 8.3.2 Market Size and Forecast, by Region
  • 8.4 Instruments
    • 8.4.1 Key Market Trends & Opportunity Analysis
    • 8.4.2 Market Size and Forecast, by Region
  • 8.5 Software
    • 8.5.1 Key Market Trends & Opportunity Analysis
    • 8.5.2 Market Size and Forecast, by Region
  • 8.6 Consumables
    • 8.6.1 Key Market Trends & Opportunity Analysis
    • 8.6.2 Market Size and Forecast, by Region
  • 8.7 Assay Systems
    • 8.7.1 Key Market Trends & Opportunity Analysis
    • 8.7.2 Market Size and Forecast, by Region
  • 8.8 Diagnostic Devices
    • 8.8.1 Key Market Trends & Opportunity Analysis
    • 8.8.2 Market Size and Forecast, by Region
  • 8.9 Therapeutic Devices
    • 8.9.1 Key Market Trends & Opportunity Analysis
    • 8.9.2 Market Size and Forecast, by Region
  • 8.10 Others
    • 8.10.1 Key Market Trends & Opportunity Analysis
    • 8.10.2 Market Size and Forecast, by Region

9: Theranostics Market, by Services

  • 9.1 Market Overview
  • 9.2 Consultation
    • 9.2.1 Key Market Trends & Opportunity Analysis
    • 9.2.2 Market Size and Forecast, by Region
  • 9.3 Maintenance
    • 9.3.1 Key Market Trends & Opportunity Analysis
    • 9.3.2 Market Size and Forecast, by Region
  • 9.4 Installation
    • 9.4.1 Key Market Trends & Opportunity Analysis
    • 9.4.2 Market Size and Forecast, by Region
  • 9.5 Training
    • 9.5.1 Key Market Trends & Opportunity Analysis
    • 9.5.2 Market Size and Forecast, by Region
  • 9.6 Data Analysis
    • 9.6.1 Key Market Trends & Opportunity Analysis
    • 9.6.2 Market Size and Forecast, by Region
  • 9.7 Remote Monitoring
    • 9.7.1 Key Market Trends & Opportunity Analysis
    • 9.7.2 Market Size and Forecast, by Region
  • 9.8 Others
    • 9.8.1 Key Market Trends & Opportunity Analysis
    • 9.8.2 Market Size and Forecast, by Region

10: Theranostics Market, by Technology

  • 10.1 Market Overview
  • 10.2 PCR
    • 10.2.1 Key Market Trends & Opportunity Analysis
    • 10.2.2 Market Size and Forecast, by Region
  • 10.3 NGS
    • 10.3.1 Key Market Trends & Opportunity Analysis
    • 10.3.2 Market Size and Forecast, by Region
  • 10.4 Immunoassays
    • 10.4.1 Key Market Trends & Opportunity Analysis
    • 10.4.2 Market Size and Forecast, by Region
  • 10.5 Mass Spectrometry
    • 10.5.1 Key Market Trends & Opportunity Analysis
    • 10.5.2 Market Size and Forecast, by Region
  • 10.6 Microarrays
    • 10.6.1 Key Market Trends & Opportunity Analysis
    • 10.6.2 Market Size and Forecast, by Region
  • 10.7 Flow Cytometry
    • 10.7.1 Key Market Trends & Opportunity Analysis
    • 10.7.2 Market Size and Forecast, by Region
  • 10.8 Liquid Biopsies
    • 10.8.1 Key Market Trends & Opportunity Analysis
    • 10.8.2 Market Size and Forecast, by Region
  • 10.9 Others
    • 10.9.1 Key Market Trends & Opportunity Analysis
    • 10.9.2 Market Size and Forecast, by Region

11: Theranostics Market, by Component

  • 11.1 Market Overview
  • 11.2 Hardware
    • 11.2.1 Key Market Trends & Opportunity Analysis
    • 11.2.2 Market Size and Forecast, by Region
  • 11.3 Software
    • 11.3.1 Key Market Trends & Opportunity Analysis
    • 11.3.2 Market Size and Forecast, by Region
  • 11.4 Services
    • 11.4.1 Key Market Trends & Opportunity Analysis
    • 11.4.2 Market Size and Forecast, by Region
  • 11.5 Others
    • 11.5.1 Key Market Trends & Opportunity Analysis
    • 11.5.2 Market Size and Forecast, by Region

12: Theranostics Market, by Application

  • 12.1 Market Overview
  • 12.2 Oncology
    • 12.2.1 Key Market Trends & Opportunity Analysis
    • 12.2.2 Market Size and Forecast, by Region
  • 12.3 Neurology
    • 12.3.1 Key Market Trends & Opportunity Analysis
    • 12.3.2 Market Size and Forecast, by Region
  • 12.4 Cardiology
    • 12.4.1 Key Market Trends & Opportunity Analysis
    • 12.4.2 Market Size and Forecast, by Region
  • 12.5 Infectious Diseases
    • 12.5.1 Key Market Trends & Opportunity Analysis
    • 12.5.2 Market Size and Forecast, by Region
  • 12.6 Endocrinology
    • 12.6.1 Key Market Trends & Opportunity Analysis
    • 12.6.2 Market Size and Forecast, by Region
  • 12.7 Gastroenterology
    • 12.7.1 Key Market Trends & Opportunity Analysis
    • 12.7.2 Market Size and Forecast, by Region
  • 12.8 Respiratory
    • 12.8.1 Key Market Trends & Opportunity Analysis
    • 12.8.2 Market Size and Forecast, by Region
  • 12.9 Others
    • 12.9.1 Key Market Trends & Opportunity Analysis
    • 12.9.2 Market Size and Forecast, by Region

13: Theranostics Market, by End User

  • 13.1 Market Overview
  • 13.2 Hospitals
    • 13.2.1 Key Market Trends & Opportunity Analysis
    • 13.2.2 Market Size and Forecast, by Region
  • 13.3 Diagnostic Laboratories
    • 13.3.1 Key Market Trends & Opportunity Analysis
    • 13.3.2 Market Size and Forecast, by Region
  • 13.4 Research Institutes
    • 13.4.1 Key Market Trends & Opportunity Analysis
    • 13.4.2 Market Size and Forecast, by Region
  • 13.5 Pharmaceutical Companies
    • 13.5.1 Key Market Trends & Opportunity Analysis
    • 13.5.2 Market Size and Forecast, by Region
  • 13.6 Biotechnology Companies
    • 13.6.1 Key Market Trends & Opportunity Analysis
    • 13.6.2 Market Size and Forecast, by Region
  • 13.7 Academic Institutions
    • 13.7.1 Key Market Trends & Opportunity Analysis
    • 13.7.2 Market Size and Forecast, by Region
  • 13.8 Others
    • 13.8.1 Key Market Trends & Opportunity Analysis
    • 13.8.2 Market Size and Forecast, by Region

14: Theranostics Market, by Device

  • 14.1 Market Overview
  • 14.2 PET Scanners
    • 14.2.1 Key Market Trends & Opportunity Analysis
    • 14.2.2 Market Size and Forecast, by Region
  • 14.3 MRI Scanners
    • 14.3.1 Key Market Trends & Opportunity Analysis
    • 14.3.2 Market Size and Forecast, by Region
  • 14.4 CT Scanners
    • 14.4.1 Key Market Trends & Opportunity Analysis
    • 14.4.2 Market Size and Forecast, by Region
  • 14.5 Ultrasound Devices
    • 14.5.1 Key Market Trends & Opportunity Analysis
    • 14.5.2 Market Size and Forecast, by Region
  • 14.6 Gamma Cameras
    • 14.6.1 Key Market Trends & Opportunity Analysis
    • 14.6.2 Market Size and Forecast, by Region
  • 14.7 Others
    • 14.7.1 Key Market Trends & Opportunity Analysis
    • 14.7.2 Market Size and Forecast, by Region

15: Theranostics Market, by Process

  • 15.1 Market Overview
  • 15.2 In Vivo
    • 15.2.1 Key Market Trends & Opportunity Analysis
    • 15.2.2 Market Size and Forecast, by Region
  • 15.3 In Vitro
    • 15.3.1 Key Market Trends & Opportunity Analysis
    • 15.3.2 Market Size and Forecast, by Region
  • 15.4 Others
    • 15.4.1 Key Market Trends & Opportunity Analysis
    • 15.4.2 Market Size and Forecast, by Region

16: Theranostics Market, by Region

  • 16.1 Overview
  • 16.2 North America
    • 16.2.1 Key Market Trends and Opportunities
    • 16.2.2 North America Market Size and Forecast, by Type
    • 16.2.3 North America Market Size and Forecast, by Product
    • 16.2.4 North America Market Size and Forecast, by Services
    • 16.2.5 North America Market Size and Forecast, by Technology
    • 16.2.6 North America Market Size and Forecast, by Component
    • 16.2.7 North America Market Size and Forecast, by Application
    • 16.2.8 North America Market Size and Forecast, by End User
    • 16.2.9 North America Market Size and Forecast, by Device
    • 16.2.10 North America Market Size and Forecast, by Process
    • 16.2.11 North America Market Size and Forecast, by Country
    • 16.2.12 United States
      • 16.2.9.1 United States Market Size and Forecast, by Type
      • 16.2.9.2 United States Market Size and Forecast, by Product
      • 16.2.9.3 United States Market Size and Forecast, by Services
      • 16.2.9.4 United States Market Size and Forecast, by Technology
      • 16.2.9.5 United States Market Size and Forecast, by Component
      • 16.2.9.6 United States Market Size and Forecast, by Application
      • 16.2.9.7 United States Market Size and Forecast, by End User
      • 16.2.9.8 United States Market Size and Forecast, by Device
      • 16.2.9.9 United States Market Size and Forecast, by Process
      • 16.2.9.10 Local Competition Analysis
      • 16.2.9.11 Local Market Analysis
    • 16.2.1 Canada
      • 16.2.10.1 Canada Market Size and Forecast, by Type
      • 16.2.10.2 Canada Market Size and Forecast, by Product
      • 16.2.10.3 Canada Market Size and Forecast, by Services
      • 16.2.10.4 Canada Market Size and Forecast, by Technology
      • 16.2.10.5 Canada Market Size and Forecast, by Component
      • 16.2.10.6 Canada Market Size and Forecast, by Application
      • 16.2.10.7 Canada Market Size and Forecast, by End User
      • 16.2.10.8 Canada Market Size and Forecast, by Device
      • 16.2.10.9 Canada Market Size and Forecast, by Process
      • 16.2.10.10 Local Competition Analysis
      • 16.2.10.11 Local Market Analysis
  • 16.1 Europe
    • 16.3.1 Key Market Trends and Opportunities
    • 16.3.2 Europe Market Size and Forecast, by Type
    • 16.3.3 Europe Market Size and Forecast, by Product
    • 16.3.4 Europe Market Size and Forecast, by Services
    • 16.3.5 Europe Market Size and Forecast, by Technology
    • 16.3.6 Europe Market Size and Forecast, by Component
    • 16.3.7 Europe Market Size and Forecast, by Application
    • 16.3.8 Europe Market Size and Forecast, by End User
    • 16.3.9 Europe Market Size and Forecast, by Device
    • 16.3.10 Europe Market Size and Forecast, by Process
    • 16.3.11 Europe Market Size and Forecast, by Country
    • 16.3.12 United Kingdom
      • 16.3.9.1 United Kingdom Market Size and Forecast, by Type
      • 16.3.9.2 United Kingdom Market Size and Forecast, by Product
      • 16.3.9.3 United Kingdom Market Size and Forecast, by Services
      • 16.3.9.4 United Kingdom Market Size and Forecast, by Technology
      • 16.3.9.5 United Kingdom Market Size and Forecast, by Component
      • 16.3.9.6 United Kingdom Market Size and Forecast, by Application
      • 16.3.9.7 United Kingdom Market Size and Forecast, by End User
      • 16.3.9.8 United Kingdom Market Size and Forecast, by Device
      • 16.3.9.9 United Kingdom Market Size and Forecast, by Process
      • 16.3.9.10 Local Competition Analysis
      • 16.3.9.11 Local Market Analysis
    • 16.3.1 Germany
      • 16.3.10.1 Germany Market Size and Forecast, by Type
      • 16.3.10.2 Germany Market Size and Forecast, by Product
      • 16.3.10.3 Germany Market Size and Forecast, by Services
      • 16.3.10.4 Germany Market Size and Forecast, by Technology
      • 16.3.10.5 Germany Market Size and Forecast, by Component
      • 16.3.10.6 Germany Market Size and Forecast, by Application
      • 16.3.10.7 Germany Market Size and Forecast, by End User
      • 16.3.10.8 Germany Market Size and Forecast, by Device
      • 16.3.10.9 Germany Market Size and Forecast, by Process
      • 16.3.10.10 Local Competition Analysis
      • 16.3.10.11 Local Market Analysis
    • 16.3.1 France
      • 16.3.11.1 France Market Size and Forecast, by Type
      • 16.3.11.2 France Market Size and Forecast, by Product
      • 16.3.11.3 France Market Size and Forecast, by Services
      • 16.3.11.4 France Market Size and Forecast, by Technology
      • 16.3.11.5 France Market Size and Forecast, by Component
      • 16.3.11.6 France Market Size and Forecast, by Application
      • 16.3.11.7 France Market Size and Forecast, by End User
      • 16.3.11.8 France Market Size and Forecast, by Device
      • 16.3.11.9 France Market Size and Forecast, by Process
      • 16.3.11.10 Local Competition Analysis
      • 16.3.11.11 Local Market Analysis
    • 16.3.1 Spain
      • 16.3.12.1 Spain Market Size and Forecast, by Type
      • 16.3.12.2 Spain Market Size and Forecast, by Product
      • 16.3.12.3 Spain Market Size and Forecast, by Services
      • 16.3.12.4 Spain Market Size and Forecast, by Technology
      • 16.3.12.5 Spain Market Size and Forecast, by Component
      • 16.3.12.6 Spain Market Size and Forecast, by Application
      • 16.3.12.7 Spain Market Size and Forecast, by End User
      • 16.3.12.8 Spain Market Size and Forecast, by Device
      • 16.3.12.9 Spain Market Size and Forecast, by Process
      • 16.3.12.10 Local Competition Analysis
      • 16.3.12.11 Local Market Analysis
    • 16.3.1 Italy
      • 16.3.13.1 Italy Market Size and Forecast, by Type
      • 16.3.13.2 Italy Market Size and Forecast, by Product
      • 16.3.13.3 Italy Market Size and Forecast, by Services
      • 16.3.13.4 Italy Market Size and Forecast, by Technology
      • 16.3.13.5 Italy Market Size and Forecast, by Component
      • 16.3.13.6 Italy Market Size and Forecast, by Application
      • 16.3.13.7 Italy Market Size and Forecast, by End User
      • 16.3.13.8 Italy Market Size and Forecast, by Device
      • 16.3.13.9 Italy Market Size and Forecast, by Process
      • 16.3.13.10 Local Competition Analysis
      • 16.3.13.11 Local Market Analysis
    • 16.3.1 Netherlands
      • 16.3.14.1 Netherlands Market Size and Forecast, by Type
      • 16.3.14.2 Netherlands Market Size and Forecast, by Product
      • 16.3.14.3 Netherlands Market Size and Forecast, by Services
      • 16.3.14.4 Netherlands Market Size and Forecast, by Technology
      • 16.3.14.5 Netherlands Market Size and Forecast, by Component
      • 16.3.14.6 Netherlands Market Size and Forecast, by Application
      • 16.3.14.7 Netherlands Market Size and Forecast, by End User
      • 16.3.14.8 Netherlands Market Size and Forecast, by Device
      • 16.3.14.9 Netherlands Market Size and Forecast, by Process
      • 16.3.14.10 Local Competition Analysis
      • 16.3.14.11 Local Market Analysis
    • 16.3.1 Sweden
      • 16.3.15.1 Sweden Market Size and Forecast, by Type
      • 16.3.15.2 Sweden Market Size and Forecast, by Product
      • 16.3.15.3 Sweden Market Size and Forecast, by Services
      • 16.3.15.4 Sweden Market Size and Forecast, by Technology
      • 16.3.15.5 Sweden Market Size and Forecast, by Component
      • 16.3.15.6 Sweden Market Size and Forecast, by Application
      • 16.3.15.7 Sweden Market Size and Forecast, by End User
      • 16.3.15.8 Sweden Market Size and Forecast, by Device
      • 16.3.15.9 Sweden Market Size and Forecast, by Process
      • 16.3.15.10 Local Competition Analysis
      • 16.3.15.11 Local Market Analysis
    • 16.3.1 Switzerland
      • 16.3.16.1 Switzerland Market Size and Forecast, by Type
      • 16.3.16.2 Switzerland Market Size and Forecast, by Product
      • 16.3.16.3 Switzerland Market Size and Forecast, by Services
      • 16.3.16.4 Switzerland Market Size and Forecast, by Technology
      • 16.3.16.5 Switzerland Market Size and Forecast, by Component
      • 16.3.16.6 Switzerland Market Size and Forecast, by Application
      • 16.3.16.7 Switzerland Market Size and Forecast, by End User
      • 16.3.16.8 Switzerland Market Size and Forecast, by Device
      • 16.3.16.9 Switzerland Market Size and Forecast, by Process
      • 16.3.16.10 Local Competition Analysis
      • 16.3.16.11 Local Market Analysis
    • 16.3.1 Denmark
      • 16.3.17.1 Denmark Market Size and Forecast, by Type
      • 16.3.17.2 Denmark Market Size and Forecast, by Product
      • 16.3.17.3 Denmark Market Size and Forecast, by Services
      • 16.3.17.4 Denmark Market Size and Forecast, by Technology
      • 16.3.17.5 Denmark Market Size and Forecast, by Component
      • 16.3.17.6 Denmark Market Size and Forecast, by Application
      • 16.3.17.7 Denmark Market Size and Forecast, by End User
      • 16.3.17.8 Denmark Market Size and Forecast, by Device
      • 16.3.17.9 Denmark Market Size and Forecast, by Process
      • 16.3.17.10 Local Competition Analysis
      • 16.3.17.11 Local Market Analysis
    • 16.3.1 Finland
      • 16.3.18.1 Finland Market Size and Forecast, by Type
      • 16.3.18.2 Finland Market Size and Forecast, by Product
      • 16.3.18.3 Finland Market Size and Forecast, by Services
      • 16.3.18.4 Finland Market Size and Forecast, by Technology
      • 16.3.18.5 Finland Market Size and Forecast, by Component
      • 16.3.18.6 Finland Market Size and Forecast, by Application
      • 16.3.18.7 Finland Market Size and Forecast, by End User
      • 16.3.18.8 Finland Market Size and Forecast, by Device
      • 16.3.18.9 Finland Market Size and Forecast, by Process
      • 16.3.18.10 Local Competition Analysis
      • 16.3.18.11 Local Market Analysis
    • 16.3.1 Russia
      • 16.3.19.1 Russia Market Size and Forecast, by Type
      • 16.3.19.2 Russia Market Size and Forecast, by Product
      • 16.3.19.3 Russia Market Size and Forecast, by Services
      • 16.3.19.4 Russia Market Size and Forecast, by Technology
      • 16.3.19.5 Russia Market Size and Forecast, by Component
      • 16.3.19.6 Russia Market Size and Forecast, by Application
      • 16.3.19.7 Russia Market Size and Forecast, by End User
      • 16.3.19.8 Russia Market Size and Forecast, by Device
      • 16.3.19.9 Russia Market Size and Forecast, by Process
      • 16.3.19.10 Local Competition Analysis
      • 16.3.19.11 Local Market Analysis
    • 16.3.1 Rest of Europe
      • 16.3.20.1 Rest of Europe Market Size and Forecast, by Type
      • 16.3.20.2 Rest of Europe Market Size and Forecast, by Product
      • 16.3.20.3 Rest of Europe Market Size and Forecast, by Services
      • 16.3.20.4 Rest of Europe Market Size and Forecast, by Technology
      • 16.3.20.5 Rest of Europe Market Size and Forecast, by Component
      • 16.3.20.6 Rest of Europe Market Size and Forecast, by Application
      • 16.3.20.7 Rest of Europe Market Size and Forecast, by End User
      • 16.3.20.8 Rest of Europe Market Size and Forecast, by Device
      • 16.3.20.9 Rest of Europe Market Size and Forecast, by Process
      • 16.3.20.10 Local Competition Analysis
      • 16.3.20.11 Local Market Analysis
  • 16.1 Asia-Pacific
    • 16.4.1 Key Market Trends and Opportunities
    • 16.4.2 Asia-Pacific Market Size and Forecast, by Type
    • 16.4.3 Asia-Pacific Market Size and Forecast, by Product
    • 16.4.4 Asia-Pacific Market Size and Forecast, by Services
    • 16.4.5 Asia-Pacific Market Size and Forecast, by Technology
    • 16.4.6 Asia-Pacific Market Size and Forecast, by Component
    • 16.4.7 Asia-Pacific Market Size and Forecast, by Application
    • 16.4.8 Asia-Pacific Market Size and Forecast, by End User
    • 16.4.9 Asia-Pacific Market Size and Forecast, by Device
    • 16.4.10 Asia-Pacific Market Size and Forecast, by Process
    • 16.4.11 Asia-Pacific Market Size and Forecast, by Country
    • 16.4.12 China
      • 16.4.9.1 China Market Size and Forecast, by Type
      • 16.4.9.2 China Market Size and Forecast, by Product
      • 16.4.9.3 China Market Size and Forecast, by Services
      • 16.4.9.4 China Market Size and Forecast, by Technology
      • 16.4.9.5 China Market Size and Forecast, by Component
      • 16.4.9.6 China Market Size and Forecast, by Application
      • 16.4.9.7 China Market Size and Forecast, by End User
      • 16.4.9.8 China Market Size and Forecast, by Device
      • 16.4.9.9 China Market Size and Forecast, by Process
      • 16.4.9.10 Local Competition Analysis
      • 16.4.9.11 Local Market Analysis
    • 16.4.1 India
      • 16.4.10.1 India Market Size and Forecast, by Type
      • 16.4.10.2 India Market Size and Forecast, by Product
      • 16.4.10.3 India Market Size and Forecast, by Services
      • 16.4.10.4 India Market Size and Forecast, by Technology
      • 16.4.10.5 India Market Size and Forecast, by Component
      • 16.4.10.6 India Market Size and Forecast, by Application
      • 16.4.10.7 India Market Size and Forecast, by End User
      • 16.4.10.8 India Market Size and Forecast, by Device
      • 16.4.10.9 India Market Size and Forecast, by Process
      • 16.4.10.10 Local Competition Analysis
      • 16.4.10.11 Local Market Analysis
    • 16.4.1 Japan
      • 16.4.11.1 Japan Market Size and Forecast, by Type
      • 16.4.11.2 Japan Market Size and Forecast, by Product
      • 16.4.11.3 Japan Market Size and Forecast, by Services
      • 16.4.11.4 Japan Market Size and Forecast, by Technology
      • 16.4.11.5 Japan Market Size and Forecast, by Component
      • 16.4.11.6 Japan Market Size and Forecast, by Application
      • 16.4.11.7 Japan Market Size and Forecast, by End User
      • 16.4.11.8 Japan Market Size and Forecast, by Device
      • 16.4.11.9 Japan Market Size and Forecast, by Process
      • 16.4.11.10 Local Competition Analysis
      • 16.4.11.11 Local Market Analysis
    • 16.4.1 South Korea
      • 16.4.12.1 South Korea Market Size and Forecast, by Type
      • 16.4.12.2 South Korea Market Size and Forecast, by Product
      • 16.4.12.3 South Korea Market Size and Forecast, by Services
      • 16.4.12.4 South Korea Market Size and Forecast, by Technology
      • 16.4.12.5 South Korea Market Size and Forecast, by Component
      • 16.4.12.6 South Korea Market Size and Forecast, by Application
      • 16.4.12.7 South Korea Market Size and Forecast, by End User
      • 16.4.12.8 South Korea Market Size and Forecast, by Device
      • 16.4.12.9 South Korea Market Size and Forecast, by Process
      • 16.4.12.10 Local Competition Analysis
      • 16.4.12.11 Local Market Analysis
    • 16.4.1 Australia
      • 16.4.13.1 Australia Market Size and Forecast, by Type
      • 16.4.13.2 Australia Market Size and Forecast, by Product
      • 16.4.13.3 Australia Market Size and Forecast, by Services
      • 16.4.13.4 Australia Market Size and Forecast, by Technology
      • 16.4.13.5 Australia Market Size and Forecast, by Component
      • 16.4.13.6 Australia Market Size and Forecast, by Application
      • 16.4.13.7 Australia Market Size and Forecast, by End User
      • 16.4.13.8 Australia Market Size and Forecast, by Device
      • 16.4.13.9 Australia Market Size and Forecast, by Process
      • 16.4.13.10 Local Competition Analysis
      • 16.4.13.11 Local Market Analysis
    • 16.4.1 Singapore
      • 16.4.14.1 Singapore Market Size and Forecast, by Type
      • 16.4.14.2 Singapore Market Size and Forecast, by Product
      • 16.4.14.3 Singapore Market Size and Forecast, by Services
      • 16.4.14.4 Singapore Market Size and Forecast, by Technology
      • 16.4.14.5 Singapore Market Size and Forecast, by Component
      • 16.4.14.6 Singapore Market Size and Forecast, by Application
      • 16.4.14.7 Singapore Market Size and Forecast, by End User
      • 16.4.14.8 Singapore Market Size and Forecast, by Device
      • 16.4.14.9 Singapore Market Size and Forecast, by Process
      • 16.4.14.10 Local Competition Analysis
      • 16.4.14.11 Local Market Analysis
    • 16.4.1 Indonesia
      • 16.4.15.1 Indonesia Market Size and Forecast, by Type
      • 16.4.15.2 Indonesia Market Size and Forecast, by Product
      • 16.4.15.3 Indonesia Market Size and Forecast, by Services
      • 16.4.15.4 Indonesia Market Size and Forecast, by Technology
      • 16.4.15.5 Indonesia Market Size and Forecast, by Component
      • 16.4.15.6 Indonesia Market Size and Forecast, by Application
      • 16.4.15.7 Indonesia Market Size and Forecast, by End User
      • 16.4.15.8 Indonesia Market Size and Forecast, by Device
      • 16.4.15.9 Indonesia Market Size and Forecast, by Process
      • 16.4.15.10 Local Competition Analysis
      • 16.4.15.11 Local Market Analysis
    • 16.4.1 Taiwan
      • 16.4.16.1 Taiwan Market Size and Forecast, by Type
      • 16.4.16.2 Taiwan Market Size and Forecast, by Product
      • 16.4.16.3 Taiwan Market Size and Forecast, by Services
      • 16.4.16.4 Taiwan Market Size and Forecast, by Technology
      • 16.4.16.5 Taiwan Market Size and Forecast, by Component
      • 16.4.16.6 Taiwan Market Size and Forecast, by Application
      • 16.4.16.7 Taiwan Market Size and Forecast, by End User
      • 16.4.16.8 Taiwan Market Size and Forecast, by Device
      • 16.4.16.9 Taiwan Market Size and Forecast, by Process
      • 16.4.16.10 Local Competition Analysis
      • 16.4.16.11 Local Market Analysis
    • 16.4.1 Malaysia
      • 16.4.17.1 Malaysia Market Size and Forecast, by Type
      • 16.4.17.2 Malaysia Market Size and Forecast, by Product
      • 16.4.17.3 Malaysia Market Size and Forecast, by Services
      • 16.4.17.4 Malaysia Market Size and Forecast, by Technology
      • 16.4.17.5 Malaysia Market Size and Forecast, by Component
      • 16.4.17.6 Malaysia Market Size and Forecast, by Application
      • 16.4.17.7 Malaysia Market Size and Forecast, by End User
      • 16.4.17.8 Malaysia Market Size and Forecast, by Device
      • 16.4.17.9 Malaysia Market Size and Forecast, by Process
      • 16.4.17.10 Local Competition Analysis
      • 16.4.17.11 Local Market Analysis
    • 16.4.1 Rest of Asia-Pacific
      • 16.4.18.1 Rest of Asia-Pacific Market Size and Forecast, by Type
      • 16.4.18.2 Rest of Asia-Pacific Market Size and Forecast, by Product
      • 16.4.18.3 Rest of Asia-Pacific Market Size and Forecast, by Services
      • 16.4.18.4 Rest of Asia-Pacific Market Size and Forecast, by Technology
      • 16.4.18.5 Rest of Asia-Pacific Market Size and Forecast, by Component
      • 16.4.18.6 Rest of Asia-Pacific Market Size and Forecast, by Application
      • 16.4.18.7 Rest of Asia-Pacific Market Size and Forecast, by End User
      • 16.4.18.8 Rest of Asia-Pacific Market Size and Forecast, by Device
      • 16.4.18.9 Rest of Asia-Pacific Market Size and Forecast, by Process
      • 16.4.18.10 Local Competition Analysis
      • 16.4.18.11 Local Market Analysis
  • 16.1 Latin America
    • 16.5.1 Key Market Trends and Opportunities
    • 16.5.2 Latin America Market Size and Forecast, by Type
    • 16.5.3 Latin America Market Size and Forecast, by Product
    • 16.5.4 Latin America Market Size and Forecast, by Services
    • 16.5.5 Latin America Market Size and Forecast, by Technology
    • 16.5.6 Latin America Market Size and Forecast, by Component
    • 16.5.7 Latin America Market Size and Forecast, by Application
    • 16.5.8 Latin America Market Size and Forecast, by End User
    • 16.5.9 Latin America Market Size and Forecast, by Device
    • 16.5.10 Latin America Market Size and Forecast, by Process
    • 16.5.11 Latin America Market Size and Forecast, by Country
    • 16.5.12 Brazil
      • 16.5.9.1 Brazil Market Size and Forecast, by Type
      • 16.5.9.2 Brazil Market Size and Forecast, by Product
      • 16.5.9.3 Brazil Market Size and Forecast, by Services
      • 16.5.9.4 Brazil Market Size and Forecast, by Technology
      • 16.5.9.5 Brazil Market Size and Forecast, by Component
      • 16.5.9.6 Brazil Market Size and Forecast, by Application
      • 16.5.9.7 Brazil Market Size and Forecast, by End User
      • 16.5.9.8 Brazil Market Size and Forecast, by Device
      • 16.5.9.9 Brazil Market Size and Forecast, by Process
      • 16.5.9.10 Local Competition Analysis
      • 16.5.9.11 Local Market Analysis
    • 16.5.1 Mexico
      • 16.5.10.1 Mexico Market Size and Forecast, by Type
      • 16.5.10.2 Mexico Market Size and Forecast, by Product
      • 16.5.10.3 Mexico Market Size and Forecast, by Services
      • 16.5.10.4 Mexico Market Size and Forecast, by Technology
      • 16.5.10.5 Mexico Market Size and Forecast, by Component
      • 16.5.10.6 Mexico Market Size and Forecast, by Application
      • 16.5.10.7 Mexico Market Size and Forecast, by End User
      • 16.5.10.8 Mexico Market Size and Forecast, by Device
      • 16.5.10.9 Mexico Market Size and Forecast, by Process
      • 16.5.10.10 Local Competition Analysis
      • 16.5.10.11 Local Market Analysis
    • 16.5.1 Argentina
      • 16.5.11.1 Argentina Market Size and Forecast, by Type
      • 16.5.11.2 Argentina Market Size and Forecast, by Product
      • 16.5.11.3 Argentina Market Size and Forecast, by Services
      • 16.5.11.4 Argentina Market Size and Forecast, by Technology
      • 16.5.11.5 Argentina Market Size and Forecast, by Component
      • 16.5.11.6 Argentina Market Size and Forecast, by Application
      • 16.5.11.7 Argentina Market Size and Forecast, by End User
      • 16.5.11.8 Argentina Market Size and Forecast, by Device
      • 16.5.11.9 Argentina Market Size and Forecast, by Process
      • 16.5.11.10 Local Competition Analysis
      • 16.5.11.11 Local Market Analysis
    • 16.5.1 Rest of Latin America
      • 16.5.12.1 Rest of Latin America Market Size and Forecast, by Type
      • 16.5.12.2 Rest of Latin America Market Size and Forecast, by Product
      • 16.5.12.3 Rest of Latin America Market Size and Forecast, by Services
      • 16.5.12.4 Rest of Latin America Market Size and Forecast, by Technology
      • 16.5.12.5 Rest of Latin America Market Size and Forecast, by Component
      • 16.5.12.6 Rest of Latin America Market Size and Forecast, by Application
      • 16.5.12.7 Rest of Latin America Market Size and Forecast, by End User
      • 16.5.12.8 Rest of Latin America Market Size and Forecast, by Device
      • 16.5.12.9 Rest of Latin America Market Size and Forecast, by Process
      • 16.5.12.10 Local Competition Analysis
      • 16.5.12.11 Local Market Analysis
  • 16.1 Middle East and Africa
    • 16.6.1 Key Market Trends and Opportunities
    • 16.6.2 Middle East and Africa Market Size and Forecast, by Type
    • 16.6.3 Middle East and Africa Market Size and Forecast, by Product
    • 16.6.4 Middle East and Africa Market Size and Forecast, by Services
    • 16.6.5 Middle East and Africa Market Size and Forecast, by Technology
    • 16.6.6 Middle East and Africa Market Size and Forecast, by Component
    • 16.6.7 Middle East and Africa Market Size and Forecast, by Application
    • 16.6.8 Middle East and Africa Market Size and Forecast, by End User
    • 16.6.9 Middle East and Africa Market Size and Forecast, by Device
    • 16.6.10 Middle East and Africa Market Size and Forecast, by Process
    • 16.6.11 Middle East and Africa Market Size and Forecast, by Country
    • 16.6.12 Saudi Arabia
      • 16.6.9.1 Saudi Arabia Market Size and Forecast, by Type
      • 16.6.9.2 Saudi Arabia Market Size and Forecast, by Product
      • 16.6.9.3 Saudi Arabia Market Size and Forecast, by Services
      • 16.6.9.4 Saudi Arabia Market Size and Forecast, by Technology
      • 16.6.9.5 Saudi Arabia Market Size and Forecast, by Component
      • 16.6.9.6 Saudi Arabia Market Size and Forecast, by Application
      • 16.6.9.7 Saudi Arabia Market Size and Forecast, by End User
      • 16.6.9.8 Saudi Arabia Market Size and Forecast, by Device
      • 16.6.9.9 Saudi Arabia Market Size and Forecast, by Process
      • 16.6.9.10 Local Competition Analysis
      • 16.6.9.11 Local Market Analysis
    • 16.6.1 UAE
      • 16.6.10.1 UAE Market Size and Forecast, by Type
      • 16.6.10.2 UAE Market Size and Forecast, by Product
      • 16.6.10.3 UAE Market Size and Forecast, by Services
      • 16.6.10.4 UAE Market Size and Forecast, by Technology
      • 16.6.10.5 UAE Market Size and Forecast, by Component
      • 16.6.10.6 UAE Market Size and Forecast, by Application
      • 16.6.10.7 UAE Market Size and Forecast, by End User
      • 16.6.10.8 UAE Market Size and Forecast, by Device
      • 16.6.10.9 UAE Market Size and Forecast, by Process
      • 16.6.10.10 Local Competition Analysis
      • 16.6.10.11 Local Market Analysis
    • 16.6.1 South Africa
      • 16.6.11.1 South Africa Market Size and Forecast, by Type
      • 16.6.11.2 South Africa Market Size and Forecast, by Product
      • 16.6.11.3 South Africa Market Size and Forecast, by Services
      • 16.6.11.4 South Africa Market Size and Forecast, by Technology
      • 16.6.11.5 South Africa Market Size and Forecast, by Component
      • 16.6.11.6 South Africa Market Size and Forecast, by Application
      • 16.6.11.7 South Africa Market Size and Forecast, by End User
      • 16.6.11.8 South Africa Market Size and Forecast, by Device
      • 16.6.11.9 South Africa Market Size and Forecast, by Process
      • 16.6.11.10 Local Competition Analysis
      • 16.6.11.11 Local Market Analysis
    • 16.6.1 Rest of MEA
      • 16.6.12.1 Rest of MEA Market Size and Forecast, by Type
      • 16.6.12.2 Rest of MEA Market Size and Forecast, by Product
      • 16.6.12.3 Rest of MEA Market Size and Forecast, by Services
      • 16.6.12.4 Rest of MEA Market Size and Forecast, by Technology
      • 16.6.12.5 Rest of MEA Market Size and Forecast, by Component
      • 16.6.12.6 Rest of MEA Market Size and Forecast, by Application
      • 16.6.12.7 Rest of MEA Market Size and Forecast, by End User
      • 16.6.12.8 Rest of MEA Market Size and Forecast, by Device
      • 16.6.12.9 Rest of MEA Market Size and Forecast, by Process
      • 16.6.12.10 Local Competition Analysis
      • 16.6.12.11 Local Market Analysis

17: Competitive Landscape

  • 17.1 Overview
  • 17.2 Market Share Analysis
  • 17.3 Key Player Positioning
  • 17.4 Competitive Leadership Mapping
    • 17.4.1 Star Players
    • 17.4.2 Innovators
    • 17.4.3 Emerging Players
  • 17.5 Vendor Benchmarking
  • 17.6 Developmental Strategy Benchmarking
    • 17.6.1 New Product Developments
    • 17.6.2 Product Launches
    • 17.6.3 Business Expansions
    • 17.6.4 Partnerships, Joint Ventures, and Collaborations
    • 17.6.5 Mergers and Acquisitions

18: Company Profiles

  • 18.1 Advanced Accelerator Applications
    • 18.1.1 Company Overview
    • 18.1.2 Company Snapshot
    • 18.1.3 Business Segments
    • 18.1.4 Business Performance
    • 18.1.5 Product Offerings
    • 18.1.6 Key Developmental Strategies
    • 18.1.7 SWOT Analysis
  • 18.2 Theragnostics
    • 18.2.1 Company Overview
    • 18.2.2 Company Snapshot
    • 18.2.3 Business Segments
    • 18.2.4 Business Performance
    • 18.2.5 Product Offerings
    • 18.2.6 Key Developmental Strategies
    • 18.2.7 SWOT Analysis
  • 18.3 Lantheus Holdings
    • 18.3.1 Company Overview
    • 18.3.2 Company Snapshot
    • 18.3.3 Business Segments
    • 18.3.4 Business Performance
    • 18.3.5 Product Offerings
    • 18.3.6 Key Developmental Strategies
    • 18.3.7 SWOT Analysis
  • 18.4 NanoMab Technology
    • 18.4.1 Company Overview
    • 18.4.2 Company Snapshot
    • 18.4.3 Business Segments
    • 18.4.4 Business Performance
    • 18.4.5 Product Offerings
    • 18.4.6 Key Developmental Strategies
    • 18.4.7 SWOT Analysis
  • 18.5 Radiomedix
    • 18.5.1 Company Overview
    • 18.5.2 Company Snapshot
    • 18.5.3 Business Segments
    • 18.5.4 Business Performance
    • 18.5.5 Product Offerings
    • 18.5.6 Key Developmental Strategies
    • 18.5.7 SWOT Analysis
  • 18.6 Telix Pharmaceuticals
    • 18.6.1 Company Overview
    • 18.6.2 Company Snapshot
    • 18.6.3 Business Segments
    • 18.6.4 Business Performance
    • 18.6.5 Product Offerings
    • 18.6.6 Key Developmental Strategies
    • 18.6.7 SWOT Analysis
  • 18.7 Blue Earth Diagnostics
    • 18.7.1 Company Overview
    • 18.7.2 Company Snapshot
    • 18.7.3 Business Segments
    • 18.7.4 Business Performance
    • 18.7.5 Product Offerings
    • 18.7.6 Key Developmental Strategies
    • 18.7.7 SWOT Analysis
  • 18.8 Isotopia Molecular Imaging
    • 18.8.1 Company Overview
    • 18.8.2 Company Snapshot
    • 18.8.3 Business Segments
    • 18.8.4 Business Performance
    • 18.8.5 Product Offerings
    • 18.8.6 Key Developmental Strategies
    • 18.8.7 SWOT Analysis
  • 18.9 Sofie Biosciences
    • 18.9.1 Company Overview
    • 18.9.2 Company Snapshot
    • 18.9.3 Business Segments
    • 18.9.4 Business Performance
    • 18.9.5 Product Offerings
    • 18.9.6 Key Developmental Strategies
    • 18.9.7 SWOT Analysis
  • 18.10 Endocyte
    • 18.10.1 Company Overview
    • 18.10.2 Company Snapshot
    • 18.10.3 Business Segments
    • 18.10.4 Business Performance
    • 18.10.5 Product Offerings
    • 18.10.6 Key Developmental Strategies
    • 18.10.7 SWOT Analysis
  • 18.11 Navidea Biopharmaceuticals
    • 18.11.1 Company Overview
    • 18.11.2 Company Snapshot
    • 18.11.3 Business Segments
    • 18.11.4 Business Performance
    • 18.11.5 Product Offerings
    • 18.11.6 Key Developmental Strategies
    • 18.11.7 SWOT Analysis
  • 18.12 Cyclopharm
    • 18.12.1 Company Overview
    • 18.12.2 Company Snapshot
    • 18.12.3 Business Segments
    • 18.12.4 Business Performance
    • 18.12.5 Product Offerings
    • 18.12.6 Key Developmental Strategies
    • 18.12.7 SWOT Analysis
  • 18.13 ImaginAb
    • 18.13.1 Company Overview
    • 18.13.2 Company Snapshot
    • 18.13.3 Business Segments
    • 18.13.4 Business Performance
    • 18.13.5 Product Offerings
    • 18.13.6 Key Developmental Strategies
    • 18.13.7 SWOT Analysis
  • 18.14 OncoNano Medicine
    • 18.14.1 Company Overview
    • 18.14.2 Company Snapshot
    • 18.14.3 Business Segments
    • 18.14.4 Business Performance
    • 18.14.5 Product Offerings
    • 18.14.6 Key Developmental Strategies
    • 18.14.7 SWOT Analysis
  • 18.15 Cerveau Technologies
    • 18.15.1 Company Overview
    • 18.15.2 Company Snapshot
    • 18.15.3 Business Segments
    • 18.15.4 Business Performance
    • 18.15.5 Product Offerings
    • 18.15.6 Key Developmental Strategies
    • 18.15.7 SWOT Analysis